Retatrutide – 30mg

Retatrutide is a next-generation synthetic peptide with a unique
triple-agonist mechanism, targeting GLP-1, GIP, and glucagon receptors.
This multi-receptor activation has made it a promising compound in research
on weight management, glycemic control, and energy expenditure.
The 30mg vial offers an intermediate dosage format suitable for extended metabolic research studies.

Potential Research Benefits

• Explored for weight reduction and appetite control
• Studied for glucose metabolism & insulin sensitivity
• Supports lipid regulation & energy expenditure
• Triple receptor activation: GLP-1, GIP & glucagon

Scientific Background

Retatrutide’s simultaneous engagement of GLP-1, GIP, and glucagon receptors
sets it apart from dual-agonist peptides.
Early research suggests that this combined activity may provide greater improvements
in weight management, glycemic regulation, and energy balance.
Its unique receptor profile has positioned it at the forefront of
next-generation metabolic research.

Product Details

• Compound: Retatrutide
• Form: Lyophilized Powder
• Amount: 30mg per vial
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption